Ventyx Biosciences (VTYX) Financials

$14.00

$0.00 (0.00%)

As on 06-Mar-2026 09:30EDT

Market cap

$1,005 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

5.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	1.45	--	--	--	--	--
Cost of Revenue	0.68	1.35	0.94	0.47	0.03	--
Gross Profit	0.05	-1.35	-0.94	-0.47	-0.03	--
Operating Expenses	116.72	148.45	207.99	113.14	67.15	7.05
Operating Profit (EBIT)	-116.72	-148.45	-207.99	-113.14	-67.15	-7.05
Other Income	--	--	--	4.71	-16.50	--
Profit before Tax	-106.61	-135.12	-192.96	-108.43	-83.75	-28.17
Provision for Tax	--	--	--	-0.47	-5.38	0.36
Profit after Tax (Net Income)	-106.61	-135.12	-192.96	-108.43	-83.75	-28.17
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-108.43	-85.30	-28.17

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	191.36	254.05	243.92	353.90	279.20	-30.65
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	8.84	9.74	11.51	1.15	4.66	29.50
Current Liabilities	11.26	12.78	22.27	16.36	12.28	1.40
Total Liabilities	222.72	276.56	277.69	371.40	291.48	0.25

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	10.37	46.94	13.35	40.71	28.46	--
Current Assets	201.09	229.63	264.35	330.69	263.02	0.25
Total Assets	222.72	276.56	277.69	371.40	291.48	0.25
Total Debt*	10.02	10.79	12.51	1.56	--	12.65
Net Current Assets	189.84	216.85	242.08	314.33	250.74	-1.16

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-130.87	-166.52	-98.77	-38.65	-6.20
Cash Flow from Investing Activities	--	-15.51	100.94	-74.93	-214.37	-214.37
Cash from Financing Activities	--	122.12	53.33	167.77	323.55	6.13
Net Cash Inflow / Outflow	--	--	--	-5.93	70.55	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.50	-1.91	-3.27	-1.91	-1.77	-0.58
Cash EPS ($)	--	-1.89	-3.25	-1.90	-1.77	-0.58
Adjusted Book Value ($)	--	3.59	4.13	6.24	5.91	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.85	-2.82	-1.74	-0.82	-0.13
Free Cash Flow per Share ($)	--	-1.85	-2.83	-1.75	-0.82	-0.13

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-51.84	-63.07	-34.17	-64.13	308.10
ROE (%)	-50.41	-54.27	-64.56	-34.25	-67.39	162.00
ROA (%)	-39.77	-48.76	-59.46	-32.71	-57.41	-9,486.20
EBIT Margin (%)	-7,919.68	--	--	--	--	--
Net Margin (%)	-7,362.36	--	--	-2,302.04	507.55	--
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	34.57	--	--	--	--	--
EBIT Growth (%)	31.07	28.63	-83.84	-35.25	-493.20	-237.26
Net Profit Growth (%)	30.10	29.97	-77.97	-29.47	-197.25	-529.87
EPS Growth (%)	36.65	0.42	-0.71	-0.08	-2.07	--
Book Value Growth (%)	-31.97	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-1.15	-0.76	-17.15	-11.21	--
Price / Book Value	5.25	0.61	0.60	5.26	3.36	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-22.93	0.35	0.45	-13.70	-8.13	--
Close Price ($)	3.11	2.19	2.47	32.79	19.86	--
High Price ($)	3.39	11.48	47.25	41.29	26.00	--
Low Price ($)	0.78	1.67	2.06	9.50	13.95	--
Market Cap ($ Cr)	1,004.50	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.04	0.05	0.00	--	-0.41
Short term debt to equity ratio	0.01	0.00	0.00	0.00	--	--
Current Ratio	17.86	17.97	11.87	20.21	21.41	0.17
Quick Ratio	17.86	--	11.91	--	--	--
Interest Coverage	--	--	--	-24.02	-844.92	-39.39

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	34.53	--	--	--	--	--
Asset Turnover	0.01	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	-216.77	-310.52	--	--	--
Payable days	--	1,203.86	2,365.59	4,310.73	35,082.26	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.